|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.34 USD | +5.13% |
|
+14.63% | +32.56% |
| Market Cap | 2.51B 2.18B 2.04B 1.86B 3.5B 240B 3.56B 23.92B 9.37B 120B 9.44B 9.24B 400B | P/E 2026 * |
-4.29x | P/E 2027 * | 14.8x |
|---|---|---|---|---|---|
| Enterprise Value | 2.6B 2.25B 2.11B 1.92B 3.62B 248B 3.68B 24.69B 9.67B 124B 9.74B 9.53B 413B | EV / Sales 2026 * |
3.7x | EV / Sales 2027 * | 3.17x |
| Free-Float |
94.39% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioCryst Pharmaceuticals, Inc.
| 1 day | +5.08% | ||
| 1 week | +14.63% | ||
| Current month | +15.14% | ||
| 1 month | +4.34% | ||
| 3 months | +20.51% | ||
| 6 months | +51.17% | ||
| Current year | +32.56% |
| 1 week | 8.8 |  | 10.59 |
| 1 month | 8.76 | | 10.59 |
| Current year | 6.23 | | 11.22 |
| 1 year | 6 | | 11.22 |
| 3 years | 4.03 | | 11.31 |
| 5 years | 4.03 | | 19.99 |
| 10 years | 1.38 | | 19.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Gayer
CEO | Chief Executive Officer | 55 | 01/01/2026 |
Babar Ghias
DFI | Director of Finance/CFO | 47 | 07/07/2025 |
Sandeep Menon
CTO | Chief Tech/Sci/R&D Officer | 51 | 06/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Stonehouse
BRD | Director/Board Member | 65 | 01/01/2007 |
Theresa Heggie
BRD | Director/Board Member | 64 | 03/12/2018 |
Charles Gayer
BRD | Director/Board Member | 55 | 01/01/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 27/2/26 | Free | Director | 1,285 | 0.0005% | ||
| 27/2/26 | Free | Director | 528 | 0.0002% | ||
| 27/2/26 | Free | Director | 642 | 0.0003% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.13% | +14.63% | +26.10% | +48.35% | 2.51B | |
| -0.70% | +24.68% | +76.72% | +103.05% | 70.85B | |
| -2.35% | +2.88% | +35.39% | +64.72% | 55.41B | |
| -1.57% | +34.27% | +17.46% | +491.15% | 29.43B | |
| -0.30% | +18.51% | +56.61% | +4.86% | 24.12B | |
| -0.09% | +1.62% | -15.04% | -13.18% | 23.31B | |
| +0.05% | +6.12% | +46.81% | -21.81% | 18.37B | |
| +9.77% | +25.32% | +252.40% | +442.16% | 16.99B | |
| 0.00% | +10.84% | +31.14% | +628.97% | 16.1B | |
| -3.13% | -8.43% | +37.08% | +138.29% | 13.12B | |
| Average | +0.68% | +352.55% | +56.47% | +188.66% | 27.02B | |
| Weighted average by Cap. | -0.35% | +346.00% | +55.98% | +164.04% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 702M 609M 570M 520M 978M 66.98B 995M 6.68B 2.62B 33.52B 2.64B 2.58B 112B | 737M 639M 598M 546M 1.03B 70.32B 1.04B 7.01B 2.75B 35.2B 2.77B 2.71B 117B |
| Net income | -579M -502M -470M -428M -806M -55.2B -820M -5.51B -2.16B -27.63B -2.17B -2.13B -92.18B | 184M 160M 150M 137M 257M 17.59B 261M 1.75B 687M 8.81B 693M 677M 29.38B |
| Net Debt | 80.91M 70.12M 65.64M 59.89M 113M 7.72B 115M 770M 302M 3.86B 304M 297M 12.89B | -181M -157M -147M -134M -252M -17.23B -256M -1.72B -673M -8.62B -678M -663M -28.77B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/08/26 | USD 10.33 | +4.98% | 4,448,840 |
| 10/08/26 | USD 9.840 | +4.90% | 4,017,077 |
| 07/08/26 | USD 9.380 | +0.86% | 4,383,646 |
| 06/08/26 | USD 9.300 | +2.54% | 4,044,212 |
| 05/08/26 | USD 9.070 | +0.55% | 6,093,801 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BCRX Stock
Select your edition
All financial news and data tailored to specific country editions
